Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Taxes (2024 - 2025)

Historic Current Taxes for Kura Oncology (KURA) over the last 2 years, with Q1 2025 value amounting to $2.3 million.

  • Kura Oncology's Current Taxes changed N/A to $2.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2024, which is N/A changed from last year.
  • As of Q1 2025, Kura Oncology's Current Taxes stood at $2.3 million.
  • Kura Oncology's 5-year Current Taxes high stood at $2.3 million for Q1 2025, and its period low was $2.1 million during Q4 2024.